MPC-9055

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMPC-9055
Drug Alias NameViveconMPC-9055MPI-49839
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein inhibitors
TargetsCapsid protein
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMyrexis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMyrexis Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A